Angina pectoris, as a clinical syndrome, was described many years ago and the essentials in its clinical picture have remained similar to this day. Still, new observations and practice have shown that there are patients who have different presentations; for example, chest pain in women. This has led clinicians and researchers to develop new diagnostic tools such as stress echocardiography, imaging tools and even additional dynamic stimulation during coronary angiography to further enhance clinical observations. These new diagnostic tools allow for many more patients at risk to be identified offering them better and more effective treatment. The role of nitrates and its efficacy has been re-evaluated, combination treatments using ACE-inhibitors and with calcium antagonists together with a series of new drugs are undergoing tests which, if positive, can then be included in our medical management strategy. Antiplatelet drugs obviously play a major role in this approach as well.
This series looks at angina pectoris and remind us that the old adage should not be forgotten: “prevention before and above all, is needed”: keeping up-to-date, as well as analysing the risk factors and how to control them remain essential steps in our approach to angina pectoris management.
D.L. Clement, Editor-in-chief, E-journal
Date
Title
Author(s)
Our mission: To reduce the burden of cardiovascular disease.